Hyperbaric oxygen therapy for diabetic foot ulcers
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial is testing whether hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can help heal diabetic foot ulcers. It is for people with diabetes who have a foot ulcer that is not healing well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes.
- You have a diabetic foot ulcer that is grade 2, 3, or 4 (on a scale of 0–5) and has been present for more than 4 weeks.
- You are able to complete a full year of follow-up visits.
- You do not have severe COPD (GOLD stage IV), or have not had chemotherapy, immunosuppressive drugs, or systemic steroids in the last 3 months.
- You do not have cancer that has spread, severe heart failure, recent ear or chest surgery, severe epilepsy, uncontrolled high fever, or are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a new blood test (measuring carbon dioxide differences between veins and arteries) can help doctors better treat people with a severe infection in a high-pressure oxygen chamber. It is for critically ill patients already on life support.
This study tests whether giving extra treatments with hyperbaric (pressure) oxygen after a leg amputation can improve healing or recovery. It’s meant for people whose amputation happened due to long-lasting infection or poor blood flow and who can attend follow-up visits.
This study tests if special diabetic recovery shoes and an AI-guided exercise program can help people with diabetes who are receiving hyperbaric oxygen therapy. It's designed for those who can walk a little and have only minor toe loss.
This trial gives hyperbaric oxygen treatment to patients with conditions where it's not yet standard. It studies if the therapy can help people with emerging medical issues.
This trial tests a new cell treatment for diabetic foot ulcers by injecting special regulatory monocytes (OPM cells) to help heal wounds. It is for patients with mild to moderate ulcers that haven't healed for over a month.
This trial tests if a special treatment made from your own blood (platelet-rich plasma) can help heal foot ulcers in people with diabetes and poor circulation in their legs. The goal is to see if it improves wound healing compared to standard care.
Hear when a new Diabetic Foot Ulcers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.